This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Université Paul Sabatier (Toulouse III). Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Innovations of Cyril Clavel in Rheumatoid Arthritis Treatment
Introduction
Cyril Clavel is an innovative inventor based in Plaisance du Touch, France. He has made significant contributions to the field of medical science, particularly in the treatment of rheumatoid arthritis. His work focuses on the development of peptides that modulate macrophage activity, which are crucial in managing inflammatory responses.
Latest Patents
Cyril Clavel holds a patent for "Peptides modulating the activity of macrophages, usable for the treatment of rheumatoid arthritis." This invention relates to citrulline peptides that possess anti-inflammatory properties. Additionally, it includes an in vitro model for the activation of macrophages, induced by immune complexes between specified IgG of rheumatoid arthritis and their citrulline targets. He has 1 patent to his name.
Career Highlights
Throughout his career, Cyril Clavel has worked with prestigious institutions such as Université Paul Sabatier (Toulouse III) and Université de Montpellier. His research has been pivotal in advancing the understanding of rheumatoid arthritis and its treatment options.
Collaborations
Cyril has collaborated with notable colleagues, including Mireille Sebbag and Maria Leonor Nogueira. Their combined expertise has contributed to the success of his research endeavors.
Conclusion
Cyril Clavel's innovative work in the field of rheumatoid arthritis treatment showcases his dedication to advancing medical science. His contributions through patented peptides and collaborations with esteemed colleagues highlight the importance of research in developing effective therapies.